Ascentage Pharma
Focus: Ascentage Pharma is a China-based small molecule oncology company with a diversified portfolio spanning cancer therapeutics and generic/specialty products. The company generates significant revenue from both innovative cancer programs and an established base of mature marketed products.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Ascentage Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Ascentage Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
4 in 5yr
MYRBETRIQ
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$2.5B Part DStable
Peak
Help build intelligence for Ascentage Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.